We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Peptide Medication Breakthrough

News   Feb 22, 2018 | Original story from Technical University of Munich

 
Peptide Medication Breakthrough

Cyclic hexapeptide in its bioactive form with the integrin-binding tripeptide sequence arginine-glycine-aspartic acid: Green spheres represent carbon atoms, red oxygen atoms, blue nitrogen atoms and white hydrogen atoms. Yellow spheres represent the two N-methyl groups and dashed orange lines show the two intramolecular hydrogen bonds. Arrangement (clockwise): arginine (top), glycine, aspartic acid, alanine, N-methylated alanine, N-methylated D-valine. Credit: Michael Weinmueller / TUM

 
 
Advertisement
 

RELATED ARTICLES

Prevalence of Coronavirus Antibodies Declining in England

News

Tests on more than 365,000 people in England have shown that the antibody response to the virus that causes COVID-19 wanes over time.

READ MORE

The Genetic Architecture of Penicillin Allergy

News

Researchers announce the first robust evidence for the role of the major histocompatibility complex gene HLA-B in penicillin allergy to identify genetic risk factors for penicillin allergy.

READ MORE

Mapping the Immune Landscape in Pancreatic Cancer To Guide Immunotherapy

News

A new study led by the University of Michigan Rogel Cancer Center combined single-cell RNA sequencing with two other investigative techniques to create a network of interactions that suppress the body's immune response in and around pancreatic tumors.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE